%Responders to USTEKINUMAB in the cohort (WORLD):
by Thymidine Incorporation (95% CI): %20.1878 (16.4319,23.9437)
by IL-2 ELISpot (95% CI): %5.3991 (3.5211,7.7465)
by Combined Thymidine Incorporation & IL-2 ELISpot (95% CI): %5.3991 (3.5211,7.7465)
--
%Similarity between Thymidine Incorporation & IL-2 ELISpot predictions (95% CI): %85.3263 (81.888,88.7646)
